Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Protection Against COVID-19”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Testing effectiveness (Phase 2)Study completedNCT04537949
What this trial is testing

A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults

Who this might be right for
Covid-19Protection Against COVID-19
BioNTech SE 96
Not applicableStudy completedNCT05079308
What this trial is testing

Clinical Trial on the Efficacy of Different Masks With and Without a Peripheral Sealing Device, Against Covid-19

Who this might be right for
Covid19Personal Protective Equipment
University of the Balearic Islands 210
Testing effectiveness (Phase 2)Study completedNCT04649021
What this trial is testing

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population

Who this might be right for
SARS-CoV-2
BioNTech SE 960
Not applicableLooking for participantsNCT05539482
What this trial is testing

Community-Based Health Education Programs for the Early Detection of, and Vaccination Against, COVID-19 and the Adoption of Self-Protective Measures of Hong Kong Residents

Who this might be right for
COVID-19
The Hong Kong Polytechnic University 1,200
Testing effectiveness (Phase 2)Study completedNCT04949490
What this trial is testing

A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects

Who this might be right for
COVID-19SARS-CoV-2 Infection
BioNTech SE 137
Not applicableStudy completedNCT05834335
What this trial is testing

Protection Against Severe Coronavirus Disease 2019 in Patients With Multiple Sclerosis Stratified According to Disease Modifying Treatment

Who this might be right for
Multiple Sclerosis
National MS Center Melsbroek 400
Testing effectiveness (Phase 2)Study completedNCT04349631
What this trial is testing

A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19

Who this might be right for
COVID-19
Hope Biosciences Research Foundation 51
Post-approval studies (Phase 4)Study completedNCT04445428
What this trial is testing

OPV as Potential Protection Against COVID-19

Who this might be right for
Poliovirus Vaccine, OralCOVIDMortality+2 more
Bandim Health Project 3,729
Not applicableStudy completedNCT05217797
What this trial is testing

Glasses Against Transmission of SARS-CoV-2 (COVID-19) in the Community

Who this might be right for
COVID-19Respiratory Tract Infections
Norwegian Institute of Public Health 3,717
Not applicableEnded earlyNCT05012280
What this trial is testing

Malaria as a Protection Factor Against Severe COVID-19 (Known as SARS-COV-2) in the Democratic Republic of Congo (Palu-COVID)

Who this might be right for
Covid19Paludism
Institute of Tropical Medicine, Belgium 238
Not applicableUnknownNCT05613751
What this trial is testing

Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children

Who this might be right for
InfluenzaCOVID-19
University of Adelaide 1,038
Not applicableUnknownNCT05084950
What this trial is testing

Informing the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc)

Who this might be right for
SARS-CoV-2COVID-19Vaccines+1 more
Centre Scientifique de Monaco 10,000
Not applicableUnknownNCT05454631
What this trial is testing

Tolerance of Surgical Masks in Chronic Respiratory Diseases

Who this might be right for
Chronic Obstructive Pulmonary Disease
Assistance Publique - Hôpitaux de Paris 50
Early research (Phase 1)Study completedNCT04523571
What this trial is testing

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects

Who this might be right for
SARS-CoV-2
BioNTech SE 144
Testing effectiveness (Phase 2)UnknownNCT04389580
What this trial is testing

Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus

Who this might be right for
COVID-19
Kafrelsheikh University 160
Testing effectiveness (Phase 2)Ended earlyNCT04788459
What this trial is testing

Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers

Who this might be right for
COVID-19Protection Against COVID-19 and Infections With SARS-CoV- 2COVID-19 Immunisation
Takis 68
Testing effectiveness (Phase 2)Study completedNCT04380701
What this trial is testing

A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults

Who this might be right for
Infections, RespiratoryVirus DiseasesInfection Viral+3 more
BioNTech SE 512